These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1119942)

  • 21. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.
    Mishin VP; Novikov D; Hayden FG; Gubareva LV
    J Virol; 2005 Oct; 79(19):12416-24. PubMed ID: 16160169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of hemagglutinin and neuraminidase on influenza virions as revealed by immunoelectron microscopy.
    Murti KG; Webster RG
    Virology; 1986 Feb; 149(1):36-43. PubMed ID: 3511607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on adaptation of influenza virus replicated at low temperature.IV. Sensitivity of neuraminidase and hemagglutinin to some proteolytic enzymes, detergents and chemical agents.
    Brydak L
    Acta Microbiol Pol; 1990; 39(3-4):137-47. PubMed ID: 1715648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A-Turkey-Oregon-71, an avirulent influenza isolate with the hemagglutinin of fowl plague virus.
    Beard CW; Easterday BC
    Avian Dis; 1973; 17(1):173-81. PubMed ID: 4697709
    [No Abstract]   [Full Text] [Related]  

  • 25. An extract from Taxodium distichum targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro.
    Hsieh CF; Chen YL; Lin CF; Ho JY; Huang CH; Chiu CH; Hsieh PW; Horng JT
    Sci Rep; 2016 Oct; 6():36015. PubMed ID: 27796330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion.
    Schild GC; Pereira HG
    J Gen Virol; 1969 Apr; 4(3):355-63. PubMed ID: 4977660
    [No Abstract]   [Full Text] [Related]  

  • 27. Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity.
    Air GM; Laver WG
    Virology; 1995 Aug; 211(1):278-84. PubMed ID: 7645221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfer of the hemagglutinin activity of influenza virus neuraminidase subtype N9 into an N2 neuraminidase background.
    Nuss JM; Air GM
    Virology; 1991 Aug; 183(2):496-504. PubMed ID: 1853557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aromatic sialic acid analogues as potential inhibitors of influenza virus neuraminidase.
    Bianco A; Brufani M; Melchioni C
    Farmaco; 2001 Apr; 56(4):305-9. PubMed ID: 11421259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tethered neuraminidase inhibitors that bind an influenza virus: a first step towards a diagnostic method for influenza.
    McKimm-Breschkin JL; Colman PM; Jin B; Krippner GY; McDonald M; Reece PA; Tucker SP; Waddington L; Watson KG; Wu WY
    Angew Chem Int Ed Engl; 2003 Jul; 42(27):3118-21. PubMed ID: 12866095
    [No Abstract]   [Full Text] [Related]  

  • 31. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
    Enkhtaivan G; Muthuraman P; Kim DH; Mistry B
    Bioorg Med Chem; 2017 Oct; 25(20):5185-5193. PubMed ID: 28958846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of aromatic inhibitors of influenza virus neuraminidase.
    Luo M; Air GM; Brouillette WJ
    J Infect Dis; 1997 Aug; 176 Suppl 1():S62-5. PubMed ID: 9240697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential action of Aspergillus glycosidases on the hemagglutinating and neuraminidase activities of influenza and Newcastle disease viruses.
    Bikel I; Knight CA
    Virology; 1972 Jul; 49(1):326-32. PubMed ID: 5064657
    [No Abstract]   [Full Text] [Related]  

  • 34. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor.
    Lew W; Chen X; Kim CU
    Curr Med Chem; 2000 Jun; 7(6):663-72. PubMed ID: 10702632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in temperature-sensitivity of haemagglutinin and neuraminidase during adaptation of influenza virus to mice.
    Frösner GG; Gerth HJ
    Med Microbiol Immunol; 1973 Mar; 158(3):161-3. PubMed ID: 4735171
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of antineuraminidase antibody on the elution of influenza virus from cells.
    Brown J; Laver WG
    J Gen Virol; 1968 Mar; 2(2):291-5. PubMed ID: 5654766
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacophore model of influenza neuraminidase inhibitors--a systematic review.
    Gong JZ; Liu Y; Xu WF
    Pharmazie; 2009 Oct; 64(10):627-32. PubMed ID: 19947162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of a mechanism-based probe for neuraminidase to capture influenza viruses.
    Lu CP; Ren CT; Lai YN; Wu SH; Wang WM; Chen JY; Lo LC
    Angew Chem Int Ed Engl; 2005 Oct; 44(42):6888-92. PubMed ID: 16215975
    [No Abstract]   [Full Text] [Related]  

  • 39. A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity.
    Lew W; Wu H; Mendel DB; Escarpe PA; Chen X; Laver WG; Graves BJ; Kim CU
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3321-4. PubMed ID: 9873727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [M2 inhibitors and neuraminidase inhibitors].
    Klebe G; Schlitzer M
    Pharm Unserer Zeit; 2011 Mar; 40(2):144-50. PubMed ID: 21630541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.